Research Areas
In ths section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
3019 | A2764 dihydrochloride | Selective inhibitor of the TRESK potassium channel | €105.00 | |
3060 | A2793 | Inhibitor of the TRESK and TASK-1 potassium channel | €95.00 | |
2979 | ASP 2905 | Potent, selective and orally active KCNH3 (Kv12.2) inhibitor | €125.00 | |
2243 | AVE 0118 hydrochloride | Potassium channel blocker (Kv1.5 (IKur), Kv4.3 (Ito), Kir3.4 (IKAch), and IKr currents) | €120.00 | |
1112 | BMS 204352 | Maxi K+ channel opener | €105.00 | |
1309 | BMS 204352, (R)-(-)- | Potassium channel opener; Less active enantiomer of Axon 1112 | €145.00 | |
1308 | BMS 204352, (±)- | Potassium channel opener; racemate of Axon 1112 | Inquire | |
1294 | Chromanol 293B | KCNQ1 channel blocker | €95.00 | |
1322 | DMP 543 | K+ channel blocker; Ach release stimulator | €90.00 | |
2103 | Dofetilide | Kv11.1 (hERG) channel blocker | €85.00 | |
1313 | EBIO, 1- | K+ channel opener (Ca2+ activated) | €50.00 | |
1437 | Flupirtine maleate | Analgesic | €65.00 | |
2064 | Glibenclamide potassium salt | KATP channel blocker; inhibits SUR1 | €50.00 | |
1757 | HMR 1098 | K+ channel blocker (SUR1/Kir6.2 selective) | €90.00 | |
2724 | ICA-069673 | KCNQ2/KCNQ3 channel opener; Anti-convulsant | €90.00 |